Reduced-intensity conditioning regimen and allogeneic stem cell transplantation from related or unrelated HLA identical donor in neuroblastoma either refractory or relapsed after autologous stem cell transplantation

被引:0
|
作者
Prete, A.
Rondelli, R.
Lanino, E.
Pession, A.
Locatelli, F.
Zecca, M.
Messina, C.
Caselli, D.
Favre, C.
Rabusin, M.
Fagioli, F.
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S88 / S88
页数:1
相关论文
共 50 条
  • [41] Graft from HLA-identical sibling versus HLA-allelic-matched, unrelated donor (10/10) in patients undergoing allogeneic stem cell transplantation following reduced-intensity conditioning regimen
    de Berranger, E.
    Wemeau, M.
    Herbaux, C.
    Cracco, P.
    Jouet, J. -P.
    Yakoub-Agha, I.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S298 - S298
  • [42] ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION WITH REDUCED-INTENSITY CONDITIONING REGIMEN IN CHILDREN AND YOUNG ADULTS WITH NEUROBLASTOMA AND EWING SARCOMA
    Kazantsev, I.
    Gevorgyan, A.
    Kozlov, A.
    Shiryaev, S.
    Andreeva, T.
    Jukhta, T.
    Morozova, E.
    Klimov, A.
    Shvetsov, A.
    Punanov, Y.
    Safonova, S.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S204 - S204
  • [43] Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma
    Garcia, A
    Sureda, A
    Martino, R
    Valcarcel, D
    Brunet, S
    BONE MARROW TRANSPLANTATION, 2005, 35 : S200 - S200
  • [44] Reduced-intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma
    de Lavallade, Hugues
    Mohty, Mohamad
    El-Cheikh, Jean
    Cassier, Philippe A.
    Faucher, Catherine
    Furst, Sabine
    Vey, Norbert
    Stoppa, Anne-Marie
    Sainty, Daniele
    Arnoulet, Christine
    Xerri, Luc
    Gastaut, Jean-Albert
    Blaise, Didier
    Bouabdallah, Reda
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (03) : 408 - 410
  • [45] Cartilage hair hypoplasia: successful reduced-intensity conditioning stem cell transplantation from HLA-identical unrelated donor and invasive cytomegalovirus infection
    Kacinska-Pfaller, E.
    Peters, C.
    Matthes-Martin, S.
    Bonafe, L.
    Mittaz, L.
    Geyeregger, R.
    Lion, T.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S271 - S271
  • [46] Progressive multifocal leukoencephalopathy in unrelated allogeneic stem cell transplantation after reduced-intensity conditioning;: a case report
    Calistri, E.
    Tedesco, S.
    Conca, S.
    Massaro, M. T.
    Bruno, S.
    Benedetti, F.
    Bissoli, E.
    Palu, G.
    Ballerini, P. F.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S287 - S288
  • [47] Progressive multifocal leukoencephalopathy after reduced-intensity conditioning unrelated allogeneic stem cell transplantation;: A case report
    Calistri, E.
    Tedesco, S.
    Conca, S.
    Massaro, M. T.
    Bruno, S.
    Benedetti, F.
    Bissoli, E.
    Palu, G.
    Ballerini, P. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 153 - 153
  • [48] A multicenter comparison of autologous stem cell transplantation followed by reduced-intensity allogeneic stem cell transplantation with tandem autologous stem cell transplantation in multiple myeloma
    Min, Chang-Ki
    Kim, Hwak
    Kim, Kihyun
    Kwak, Jae-Yong
    Lee, Seung Tare
    Won, Jong Ho
    Yoon, Sung-Soo
    Lee, Jae Hoon
    Suh, Cheol Won
    BLOOD, 2007, 110 (11) : 286A - 286A
  • [49] ALLOGENEIC REDUCED-INTENSITY STEM CELL TRANSPLANTATION WITH FLUDARABINE AND MELPHALAN FOR REFRACTORY OR RELAPSED FOLLICULAR LYMPHOMA
    Ono, Y.
    Mori, T.
    Kato, J.
    Aisa, Y.
    Okamoto, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S236 - S236
  • [50] Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen on survival
    Anderlini, P
    Saliba, R
    Donato, M
    Andersson, B
    Ueno, N
    Khouri, I
    De Lima, M
    Ippoliti, C
    Champlin, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S11 - S11